Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study-Reference-Cited by-同舟云学术

Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study

Published:2022-12 Issue:12 Volume:48 Page:2539-2544
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Marchetti Claudia^ORCID,Arcieri Martina^ORCID,Vertechy Laura^ORCID,Ergasti Raffaella^ORCID,Russo Giorgia,Zannoni Gian Franco,Minucci Angelo,Ercoli Alfredo,Scambia Giovanni^ORCID,Fagotti Anna^ORCID

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference27 articles.

1. Hereditary ovarian cancers: state of the art;Toss;Minerva Med,2019

2. Evaluation of transvaginal ultrasound plus CA-125 measurement and prophylactic salpingo-oophorectomy in women at different risk levels of ovarian cancer: the modena study group cohort study;Cortesi;Oncology,2017

3. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations;Whittemore;Br J Cancer,2004

4. BRCA-associated cancers: role of imaging in screening, diagnosis, and management;Lee;Radiographics,2017

5. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers;Rebbeck;J Natl Cancer Inst,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations;Gynecologic Oncology;2024-10

2. Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy;Gynecologic Oncology;2024-08

3. How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature;Frontiers in Oncology;2024-03-08

4. Occult Residual Ovarian Tissue at the Time of Minimally Invasive Risk Reducing Surgery in Women with Brca Mutations;2024

5. A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany;Archives of Gynecology and Obstetrics;2023-01-27